Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-To-I RNA editing

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Fukuda, Masatora ^a   Umeno, Hiromitsu ^a   Nose, Kanako ^a   Nishitarumizu, Azusa ^a   Noguchi, Ryoma ^a   Nakagawa, Hiroyuki ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADARB1 PROTEIN, HUMAN; ADENOSINE; ADENOSINE DEAMINASE; GUIDE RNA; INOSINE; RNA BINDING PROTEIN;

CHEMISTRY; CODON; GENETICS; HEK293 CELL LINE; HUMAN; INTRACELLULAR SPACE; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; RNA EDITING; SITE DIRECTED MUTAGENESIS;

ADENOSINE; ADENOSINE DEAMINASE; BASE SEQUENCE; CODON; HEK293 CELLS; HUMANS; INOSINE; INTRACELLULAR SPACE; MUTAGENESIS, SITE-DIRECTED; PROTEIN DOMAINS; RNA EDITING; RNA, GUIDE; RNA-BINDING PROTEINS;

EID: 85011392399     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41478     Document Type: Article

References (50)

1. Heidenreich, M. & Zhang, F. Applications of CRISPR-Cas systems in neuroscience. Nat Rev Neurosci 17, 36-44 (2016).
2. Kim, Y. G., Cha, J. & Chandrasegaran, S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA 93, 1156-1160 (1996).
3. Porteus, M. H. & Carroll, D. Gene targeting using zinc finger nucleases. Nat Biotechnol 23, 967-973 (2005).
4. Zhang, F. et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29, 149-153 (2011).
5. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
6. Araki, M. & Ishii, T. Providing Appropriate Risk Information on Genome Editing for Patients. Trends Biotechnol 34, 86-90 (2016).
7. Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
8. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004).
9. Carthew, R. W. & Sontheimer, E. J. Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-655 (2009).
10. Lam, J. K., Chow, M. Y., Zhang, Y. & Leung, S. W. siRNA Versus miRNA as Therapeutics for Gene Silencing. Mol Ther Nucleic Acids 4, e252 (2015).
11. Bass, B. L. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71, 817-846 (2002).
12. Nishikura, K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79, 321-349 (2010).
13. Wulff, B. E. & Nishikura, K. Substitutional A-To-I RNA editing. WIREs RNA 1, 90-101 (2010).
14. Ganot, P., Bortolin, M. L. & Kiss, T. Site-specific pseudouridine formation in preribosomal RNA is guided by small nucleolar RNAs. Cell 89, 799-809 (1997).
15. Cavaille, J. & Bachellerie, J. P. SnoRNA-guided ribose methylation of rRNA: structural features of the guide RNA duplex influencing the extent of the reaction. Nucleic Acids Res 26, 1576-1587 (1998).
16. Weinstein, L. B. & Steitz, J. A. Guided tours: from precursor snoRNA to functional snoRNP. Curr Opin Cell Biol 11, 378-384 (1999).
17. Cavaille, J., Nicoloso, M. & Bachellerie, J. P. Targeted ribose methylation of RNA in vivo directed by tailored antisense RNA guides. Nature 383, 732-735 (1996).
18. Zhao, X. & Yu, Y. T. Targeted pre-mRNA modification for gene silencing and regulation. Nat Methods 5, 95-100 (2008).
19. Karijolich, J. & Yu, Y. T. Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 474, 395-398 (2011).
20. Vogel, P. & Stafforst, T. Site-directed RNA editing with antagomir deaminases-A tool to study protein and RNA function. ChemMedChem 9, 2021-2025 (2014).
21. Picardi, E. et al. Profiling RNA editing in human tissues: Towards the inosinome Atlas. Sci Rep 5, 14941 (2015).
22. Stafforst, T. & Schneider, M. F. An RNA-deaminase conjugate selectively repairs point mutations. Angew Chem Int Ed Engl 51, 11166-11169 (2012).
23. Schneider, M. F., Wettengel, J., Hoffmann, P. C. & Stafforst, T. Optimal guideRNAs for re-directing deaminase activity of hADAR1 and hADAR2 in trans. Nucleic Acids Res 42, e87 (2014).
24. Vogel, P., Schneider, M. F., Wettengel, J. & Stafforst, T. Improving site-directed RNA editing in vitro and in cell culture by chemical modification of the guideRNA. Angew Chem Int Ed Engl 53, 6267-6271 (2014).
25. Montiel-Gonzalez, M. F., Vallecillo-Viejo, I. C. & Rosenthal, J. J. An efficient system for selectively altering genetic information within mRNAs. Nucleic Acids Res 44, e157 (2016).
26. Montiel-Gonzalez, M. F., Vallecillo-Viejo, I., Yudowski, G. A. & Rosenthal, J. J. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc Natl Acad Sci USA 110, 18285-18290 (2013).
27. Wettengel, J., Reautschnig, P., Geisler, S., Kahle, P. J. & Stafforst, T. Harnessing human ADAR2 for RNA repair-Recoding a PINK1 mutation rescues mitophagy. Nucleic Acids Res 10.1093/nar/gkw911 (2016).
28. Vollmar, W. et al. RNA editing (R/G site) and flip-flop splicing of the AMPA receptor subunit GluR2 in nervous tissue of epilepsy patients. Neurobiol Dis 15, 371-379 (2004).
29. Nurpeisov, V., Hurwitz, S. J. & Sharma, P. L. Fluorescent dye terminator sequencing methods for quantitative determination of replication fitness of human immunodeficiency virus type 1 containing the codon 74 and 184 mutations in reverse transcriptase. J Clin Microbiol 41, 3306-3311 (2003).
30. Pokharel, S. & Beal, P. A. High-Throughput screening for functional adenosine to inosine RNA editing systems. ACS Chem Biol 1, 761-765 (2006).
31. Gommans, W. M., McCane, J., Nacarelli, G. S. & Maas, S. A mammalian reporter system for fast and quantitative detection of intracellular A-To-I RNA editing levels. Anal Biochem 399, 230-236 (2010).
32. Hanswillemenke, A., Kuzdere, T., Vogel, P., Jekely, G. & Stafforst, T. Site-Directed RNA Editing in Vivo Can Be Triggered by the Light-Driven Assembly of an Artificial Riboprotein. J Am Chem Soc 137, 15875-15881 (2015).
33. Fukuda, M., Kurihara, K., Yamaguchi, S., Oyama, Y. & Deshimaru, M. Improved design of hammerhead ribozyme for selective digestion of target RNA through recognition of site-specific adenosine-To-inosine RNA editing. RNA 20, 392-405 (2014).
34. Levanon, E. Y. et al. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res 33, 1162-1168 (2005).
35. Galeano, F. et al. Human BLCAP transcript: new editing events in normal and cancerous tissues. Int J Cancer 127, 127-137 (2010).
36. Stefl, R. et al. The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Cell 143, 225-237 (2010).
37. Eggington, J. M., Greene, T. & Bass, B. L. Predicting sites of ADAR editing in double-stranded RNA. Nat Commun 2, 319 (2011).
38. Dabiri, G. A., Lai, F., Drakas, R. A. & Nishikura, K. Editing of the GLuR-B ion channel RNA in vitro by recombinant double-stranded RNA adenosine deaminase. EMBO J 15, 34-45 (1996).
39. Yeo, J., Goodman, R. A., Schirle, N. T., David, S. S. & Beal, P. A. RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1. Proc Natl Acad Sci USA 107, 20715-20719 (2010).
40. Keegan, L. P., Leroy, A., Sproul, D. & O Connell, M. A. Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes. Genome Biol 5, 209 (2004).
41. Sansam, C. L., Wells, K. S. & Emeson, R. B. Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc Natl Acad Sci USA 100, 14018-14023 (2003).
42. Maas, S., Kawahara, Y., Tamburro, K. M. & Nishikura, K. A-To-I RNA editing and human disease. RNA Biol 3, 1-9 (2006).
43. Slotkin, W. & Nishikura, K. Adenosine-To-inosine RNA editing and human disease. Genome Med 5, 105 (2013).
44. Hideyama, T. et al. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiol Dis 45, 1121-1128 (2012).
45. Hood, J. L. & Emeson, R. B. Editing of neurotransmitter receptor and ion channel RNAs in the nervous system. Curr Top Microbiol Immunol 353, 61-90 (2012).
46. Mannion, N. M. et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 9, 1482-1494 (2014).
47. Galeano, F., Tomaselli, S., Locatelli, F. & Gallo, A. A-To-I RNA editing: The "ADAR" side of human cancer. Semin Cell Dev Biol 23, 244-250 (2012).
48. Paz, N. et al. Altered adenosine-To-inosine RNA editing in human cancer. Genome Res 17, 1586-1595 (2007).
49. Valente, L. & Nishikura, K. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. J Biol Chem 282, 16054-16061 (2007).
50. Poulsen, H. et al. Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain. RNA 12, 1350-1360 (2006).